Call in to speak with the host
Wednesday, March 25, 2014
Tonight's incredible special guest is Dr. Albert Yu from Omeros here to talk about their Phase II clinical trial with OMS824 a PDE10 inhibitor for Huntington's disease. Phase II is for tolerability, safety and pharmacokinetics. Omeros is looking for 120 patients with Huntington's disease who will be randomized to receive placebo or one of three doses of OMS824 for the treatment of cognitive impairment.
Tune in to an amazing show with Dr. Yu!
Sorry we couldn't complete your registration. Please try again.
Please enter your email to finish creating your account.
Receive a personalized list of podcasts based on your preferences.